APOGEE THERAPEUTICS INC (APGE:NASDAQ)
$133.65 0.08 (0.0599%)
Analysed APOGEE THERAPEUTICS INC (APGE:NASDAQ) News Sources
3 Under-the-Radar Biotech Takeover Targets for the Next Pharma Buying Spree
25-06-2026
247wallst.com
Is AbbVie a Buy After Its Purchase of Apogee?
25-06-2026
fool.com
2 Biotech Stocks Worth Buying Before Their Potential Buyouts
27-06-2026
fool.com
AbbVie (ABBV) to Acquire Apogee Therapeutics
27-06-2026
yahoo.com
AbbVie (ABBV) Wins Health Canada Approval for Boey
28-06-2026
yahoo.com
RBC Capital Maintains a Sector Perform Rating on Regeneron (REGN) – Here’s Why
28-06-2026
yahoo.com
AbbVie (ABBV) Moves 4.2% Higher: Will This Strength Last?
29-06-2026
yahoo.com
What Sparked the $43B Jump in AbbVie's Market Cap in the Past Week?
30-06-2026
yahoo.com
Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says
08-07-2026
yahoo.com
Apogee Therapeutics (APGE) Jumps Into Focus, Is The Stock Fully Valued?
10-07-2026
yahoo.com
What is the current price of APOGEE THERAPEUTICS INC (APGE:NASDAQ)?
The current price of APOGEE THERAPEUTICS INC (APGE:NASDAQ) is $133.65.
APOGEE THERAPEUTICS INC (APGE:NASDAQ) absolute price change since previous trading day?
The absolute price change of APOGEE THERAPEUTICS INC (APGE:NASDAQ) since the previous trading day is $0.08.
APOGEE THERAPEUTICS INC (APGE:NASDAQ) percentage price change since previous trading day?
The percentage price change of APOGEE THERAPEUTICS INC (APGE:NASDAQ) since the previous trading day is 0.0599%.
What is the most recent average sentiment score for APOGEE THERAPEUTICS INC (APGE:NASDAQ)?
The most recent average sentiment score for APOGEE THERAPEUTICS INC (APGE:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for APOGEE THERAPEUTICS INC (APGE:NASDAQ)?
The most recent sentiment for APOGEE THERAPEUTICS INC (APGE:NASDAQ) is .
SEC-8K** Filing Available For APOGEE THERAPEUTICS INC (APGE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.